Articles with "sarilumab review" as a keyword



Photo by evanthewise from unsplash

Sarilumab: A Review in Moderate to Severe Rheumatoid Arthritis

Sign Up to like & get
recommendations!
Published in 2018 at "Drugs"

DOI: 10.1007/s40265-018-0929-z

Abstract: Sarilumab (Kevzara®), a monoclonal antibody against the interleukin-6 (IL-6) receptor, is approved in various countries, including the USA, those of the EU, and Japan, as a subcutaneous treatment administered every 2 weeks for moderately to severely… read more here.

Keywords: review moderate; sarilumab review; sarilumab; rheumatoid arthritis ... See more keywords